{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:59:28Z","timestamp":1785283168061,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jdcr.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:30:14Z","timestamp":1776180614000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Paradoxical pustular psoriasis following dupilumab therapy for bullous pemphigoid: A case report"],"prefix":"10.1016","volume":"72","author":[{"given":"Melanie D.","family":"Medina-Figueroa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iancarlos","family":"Jim\u00e9nez-Sacarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Sadurn\u00ed-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mart\u00edn-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marely","family":"Santiago-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jid.2022.10.015","article-title":"IL-4\/IL-13 inhibitors for atopic dermatitis induce psoriatic rash transcriptionally close to pustular psoriasis","volume":"143","author":"Grolleau","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"19","key":"10.1016\/j.jdcr.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.3390\/jcm12196291","article-title":"\u201cDe Novo\u201d psoriasis and relapse of psoriasis induced by dupilumab: three new cases and review of the literature","volume":"12","author":"Trave","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jdcr.2026.04.005_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000530608","article-title":"Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review","volume":"239","author":"Su","year":"2023","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.jdcr.2026.04.005_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/1346-8138.14902","article-title":"Psoriasis is associated with increased risk of bullous pemphigoid: a nationwide population-based cohort study in Taiwan","volume":"46","author":"Ho","year":"2019","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.04.005_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000547774","article-title":"Sequential treatment of generalized pustular psoriasis combined with bullous pemphigoid using spesolimab and dupilumab: a case report and literature review","volume":"17","author":"Wang","year":"2025","journal-title":"Case Rep Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2026.04.005_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/exd.14791","article-title":"Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoid","volume":"32","author":"Maglie","year":"2023","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdcr.2026.04.005_bib7","article-title":"Spesolimab in the management of generalized pustular psoriasis with concurrent bullous pemphigoid and psoriasis","volume":"16","author":"Teshima","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jdcr.2026.04.005_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1148660","article-title":"Case report: coexistence of bullous pemphigoid and psoriasis: therapeutic challenge and IL17A-targeted parallel treatment strategy","volume":"10","author":"Drenovska","year":"2023","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.jdcr.2026.04.005_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2302394","article-title":"Upadacitinib for the management of bullous pemphigoid coexisting with psoriasis vulgaris: a case report and literature review","volume":"35","author":"Su","year":"2024","journal-title":"J Dermatolog Treat"},{"issue":"9","key":"10.1016\/j.jdcr.2026.04.005_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamadermatol.2023.2428","article-title":"Evaluation of dupilumab in patients with bullous pemphigoid","volume":"159","author":"Zhao","year":"2023","journal-title":"JAMA Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:27:22Z","timestamp":1785281242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"alternative-id":["S2352512626002031"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.04.005","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical pustular psoriasis following dupilumab therapy for bullous pemphigoid: A case report","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}